Radionuclides	NNS
used	VBN
in	IN
PET	NNP
scanning	NN
are	VBP
typically	RB
isotopes	NNS
with	IN
short	JJ
half	NN
lives	VBZ
such	JJ
as	IN
carbon-11	NN
(	-LRB-
~20	NNP
min	NNP
)	-RRB-
,	,
nitrogen-13	NN
(	-LRB-
~10	NNP
min	NNP
)	-RRB-
,	,
oxygen-15	NN
(	-LRB-
~2	NNP
min	NNP
)	-RRB-
,	,
and	CC
fluorine-18	NN
(	-LRB-
~110	NNP
min	NN
)	-RRB-
.	.
These	DT
radionuclides	NNS
are	VBP
incorporated	VBN
either	CC
into	IN
compounds	NNS
normally	RB
used	VBN
by	IN
the	DT
body	NN
such	JJ
as	IN
glucose	NN
(	-LRB-
or	CC
glucose	NN
analogues	NNS
)	-RRB-
,	,
water	NN
or	CC
ammonia	NN
,	,
or	CC
into	IN
molecules	NNS
that	WDT
bind	VBP
to	IN
receptors	NNS
or	CC
other	JJ
sites	NNS
of	IN
drug	NN
action	NN
.	.

Such	JJ
labelled	VBN
compounds	NNS
are	VBP
known	VBN
as	IN
radiotracers	NNS
.	.

It	PRP
is	VBZ
important	JJ
to	TO
recognize	VB
that	IN
PET	NNP
technology	NN
can	MD
be	VB
used	VBN
to	TO
trace	VB
the	DT
biologic	NN
pathway	NN
of	IN
any	DT
compound	NN
in	IN
living	VBG
humans	NNS
(	-LRB-
and	CC
many	JJ
other	JJ
species	NNS
as	RB
well	RB
)	-RRB-
,	,
provided	VBD
it	PRP
can	MD
be	VB
radiolabeled	VBN
with	IN
a	DT
PET	NNP
isotope	NN
.	.

Due	IN
to	IN
the	DT
short	JJ
half	NN
lives	NNS
of	IN
most	JJS
radioisotopes	NNS
,	,
the	DT
radiotracers	NNS
must	MD
be	VB
produced	VBN
using	VBG
a	DT
cyclotron	NN
and	CC
radiochemistry	NN
laboratory	NN
that	WDT
are	VBP
in	IN
close	JJ
proximity	NN
to	IN
the	DT
PET	NNP
imaging	NN
facility	NN
.	.

